Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site

Genes Dis. 2022 Sep 14;10(2):310-312. doi: 10.1016/j.gendis.2022.09.001. eCollection 2023 Mar.
No abstract available